TrialNaunyn-Schmiedeberg's archives of pharmacology2008
Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients.
Nicole Schupp et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled ittrialcites it